The ADC binds TROP-2 on tumor cells, is internalized, and its cleavable linker releases a topoisomerase I inhibitor that blocks DNA replication, causing DNA damage, cell-cycle arrest, and apoptosis; Fc-mediated effector functions (e.g., ADCC/CDC) may also contribute.